Docetaxel injection: clinical trials recruiting now

Phase breakdown

Conditions being studied

Recruiting trials involving Docetaxel injection

• A Study of HRS-5041 Tablets Combined With Antitumor Therapy in Subjects With Advanced Prostate Cancer
  NCT06568094 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 80 Years · Sex: Male · 2 locations
• D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy Failure
  NCT06300177 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 86 locations
• Dalpiciclib Plus AI (Neoadjuvant Endocrine Therapy) Compared With Neoadjuvant Chemotherapy in Early Breast Cancer （EBC）
  NCT06107673 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 1 location
• JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects
  NCT06079983 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 87 locations
• Study of HRS-5041 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
  NCT05942001 · Phase: Phase 1 · Ages: 18 Years to 80 Years · Sex: Male · 1 location

Common questions

How many recruiting trials involve Docetaxel injection?

5 recruiting trials across 5 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.